These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38428709)

  • 1. Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
    Narula N; Wong ECL; Dulai PS; Patel J; Marshall JK; Yzet C; Jairath V; Ungaro R; Colombel JF; Reinisch W;
    Clin Gastroenterol Hepatol; 2024 Aug; 22(8):1687-1696.e6. PubMed ID: 38428709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Categorising Endoscopic Severity of Crohn's Disease Using the Modified Multiplier SES-CD [MM-SES-CD].
    Narula N; Pray C; Wong ECL; Colombel JF; Marshall JK; Daperno M; Reinisch W; Dulai PS
    J Crohns Colitis; 2022 Aug; 16(7):1011-1019. PubMed ID: 35134140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.
    Narula N; Wong ECL; Colombel JF; Sandborn WJ; Ferrante M; Marshall JK; Reinisch W; Dulai PS
    J Crohns Colitis; 2022 May; 16(4):616-624. PubMed ID: 34664635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD).
    Narula N; Wong ECL; Colombel JF; Sandborn WJ; Marshall JK; Daperno M; Reinisch W; Dulai PS
    Gut; 2022 Jun; 71(6):1078-1087. PubMed ID: 33766910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn's Disease.
    Narula N; Wong ECL; Dulai PS; Marshall JK; Jairath V; Reinisch W
    Inflamm Bowel Dis; 2023 May; 29(5):716-725. PubMed ID: 35762666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.
    Khanna R; Nelson SA; Feagan BG; D'Haens G; Sandborn WJ; Zou GY; MacDonald JK; Parker CE; Jairath V; Levesque BG
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010642. PubMed ID: 27501379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple Enterographic Activity Score for Crohn's Disease: comparison with endoscopic, biochemical, and clinical findings.
    Eder P; Katulska K; Lykowska-Szuber L; Stawczyk-Eder K; Krela-Kaźmierczak I; Linke K
    Pol Arch Med Wewn; 2013; 123(7-8):378-85. PubMed ID: 23778300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease.
    Danese S; Sandborn WJ; Colombel JF; Vermeire S; Glover SC; Rimola J; Siegelman J; Jones S; Bornstein JD; Feagan BG
    Gastroenterology; 2019 Oct; 157(4):1007-1018.e7. PubMed ID: 31279871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of different endoscopic scoring methods in assessing disease activity in pediatric Crohn's disease].
    Deng W; Li ZY; Liu B
    Zhongguo Dang Dai Er Ke Za Zhi; 2024 Jun; 26(6):584-591. PubMed ID: 38926374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission.
    Takabayashi K; Hosoe N; Kato M; Hayashi Y; Nanki K; Fukuhara K; Mikami Y; Mizuno S; Sujino T; Mutaguchi M; Naganuma M; Yahagi N; Ogata H; Kanai T
    J Gastroenterol; 2021 Jan; 56(1):25-33. PubMed ID: 33078323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's Disease.
    Narula N; Wong ECL; Aruljothy A; Dulai PS; Colombel JF; Marshall JK; Ferrante M; Reinisch W
    J Clin Gastroenterol; 2023 Oct; 57(9):913-919. PubMed ID: 36227009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn's Disease.
    Zittan E; Kabakchiev B; Kelly OB; Milgrom R; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
    J Crohns Colitis; 2017 May; 11(5):543-548. PubMed ID: 28453763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data.
    Feagan B; Sandborn WJ; Rutgeerts P; Levesque BG; Khanna R; Huang B; Zhou Q; Maa JF; Wallace K; Lacerda A; Thakkar RB; Robinson AM
    Inflamm Bowel Dis; 2018 Apr; 24(5):932-942. PubMed ID: 29668919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endoscopic prediction model of simple endoscopic score for Crohn's disease (SES-CD) as an effective predictor of intestinal obstruction in Crohn's disease: A multicenter long-term follow-up study.
    Xu W; Hua Z; Wang Y; Gu Y; Zhong J; Cui L; Du P
    Front Surg; 2022; 9():984029. PubMed ID: 36338648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Khanna R; Zou G; Stitt L; Feagan BG; Sandborn WJ; Rutgeerts P; McDonald JWD; Dubcenco E; Fogel R; Panaccione R; Jairath V; Nelson S; Shackelton LM; Huang B; Zhou Q; Robinson AM; Levesque BG; D'Haens G
    Am J Gastroenterol; 2017 Oct; 112(10):1584-1592. PubMed ID: 28071654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease.
    E Penna FGC; Rosa RM; da Cunha PFS; de Souza SCS; de Abreu Ferrari ML
    BMC Gastroenterol; 2020 Feb; 20(1):35. PubMed ID: 32054445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal healing at 3 months predicts long-term endoscopic remission in anti-TNF-treated luminal Crohn's disease.
    af Björkesten CG; Nieminen U; Sipponen T; Turunen U; Arkkila P; Färkkilä M
    Scand J Gastroenterol; 2013 May; 48(5):543-51. PubMed ID: 23477356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease.
    Ungaro RC; Yzet C; Bossuyt P; Baert FJ; Vanasek T; D'Haens GR; Joustra VW; Panaccione R; Novacek G; Reinisch W; Armuzzi A; Golovchenko O; Prymak O; Goldis A; Travis SP; Hébuterne X; Ferrante M; Rogler G; Fumery M; Danese S; Rydzewska G; Pariente B; Hertervig E; Stanciu C; Serrero M; Diculescu M; Peyrin-Biroulet L; Laharie D; Wright JP; Gomollón F; Gubonina I; Schreiber S; Motoya S; Hellström PM; Halfvarson J; Butler JW; Petersson J; Petralia F; Colombel JF
    Gastroenterology; 2020 Jul; 159(1):139-147. PubMed ID: 32224129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
    D'Haens G; Kelly O; Battat R; Silverberg MS; Laharie D; Louis E; Savarino E; Bodini G; Yarur A; Boland BS; Afif W; Li XJ; Hale M; Ho J; Kondragunta V; Huang B; Kuy C; Okada L; Hester KD; Bray KR; Mimms L; Jain A; Singh S; Collins A; Valasek MA; Sandborn WJ; Vermeire S; Dulai PS
    Gastroenterology; 2020 Feb; 158(3):515-526.e10. PubMed ID: 31711925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.